A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers

Por Johansson, Susanne, Rosenbaum, David P., Knutsson, Mikael, Leonsson-Zachrisson, Maria
Publicado no Clin Exp Nephrol (2016)

Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study

Por Johansson, Susanne A., Knutsson, Mikael, Leonsson‐Zachrisson, Maria, Rosenbaum, David P.
Publicado no Clin Pharmacol Drug Dev (2017)

Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis

Por Block, Geoffrey A., Rosenbaum, David P., Leonsson-Zachrisson, Maria, Åstrand, Magnus, Johansson, Susanne, Knutsson, Mikael, Langkilde, Anna Maria, Chertow, Glenn M.
Publicado no J Am Soc Nephrol (2017)

Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders

Por Johansson, Susanne, Leonsson‐Zachrisson, Maria, Knutsson, Mikael, Spencer, Andrew G., Labonté, Eric D., Deshpande, Desiree, Kohler, Jill, Kozuka, Kenji, Charmot, Dominique, Rosenbaum, David P.
Publicado no Clin Pharmacol Drug Dev (2016)

Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis

Por Block, Geoffrey A., Rosenbaum, David P., Leonsson-Zachrisson, Maria, Stefansson, Bergur V., Rydén-Bergsten, Tina, Greasley, Peter J., Johansson, Susanne A., Knutsson, Mikael, Carlsson, Björn C.
Publicado no Clin J Am Soc Nephrol (2016)